Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has three separate groups. You may qualify for one of the following:
Group 1 – People with post-infectious IBS (PI-IBS):
- You are 18 years old or older
- You have been diagnosed with a specific type of IBS that developed after a gut infection, confirmed using standard diagnostic guidelines called "Rome IV criteria"
- Your diagnosis was made no more than 3 months before joining the trial
- You are willing to give written consent and follow the study procedures
Group 2 – People who had a gut infection but did NOT develop IBS:
- You are 18 years old or older
- You had an infectious stomach or gut illness more than 6 months before joining the trial
- You have fully recovered with no ongoing gut symptoms
Group 3 – Healthy volunteers:
- You are 18 years old or older
- You are a healthy donor from a stool transplant or blood donation programme
- You have no history of gut or other long-term health conditions
Who may not be able to join:
Group 1 – People with post-infectious IBS:
- You have a long-term gut condition such as Inflammatory Bowel Disease (IBD), metabolic syndrome, obesity, diabetes, gut cancer, or a systemic autoimmune condition
- You have had major surgery on your abdomen in the past
Group 2 – People who had a gut infection but did NOT develop IBS:
- You have ever been diagnosed with IBS
- You have any long-term gut or other ongoing health condition
Group 3 – Healthy volunteers:
- You have any long-term gut or other ongoing health condition
- You have taken antibiotics or probiotics within the last 4 weeks
- You regularly take medication that may affect gut bacteria, such as proton pump inhibitors (e.g. omeprazole) (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gianluca Ianiro, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630155701
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of microbial signatures discriminating PI-IBS from controls
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.